Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The dopamine type-1 receptor has been implicated in major depressive disorder (MDD) by clinical and preclinical evidence from neuroimaging, post mortem, and behavioral studies. To date, however, selective in vivo assessment of D1 receptors has been limited to the striatum in MDD samples manifesting anger attacks. We employed the PET radioligand, [11C]NNC-112, to selectively assess D1 receptor binding in extrastriatal and striatal regions in a more generalized sample of MDD subjects. The [11C]NNC-112 nondisplaceable binding potential (BPND) was assessed using PET in 18 unmedicated, currently depressed subjects with MDD and 19 healthy controls, and compared between groups using MRI-based region-of-interest analysis. The mean D1 receptor BPND was reduced (14%) in the left middle caudate of the MDD group relative to control group (p<0.05). Among the MDD subjects D1 receptor BPND in this region correlated negatively with illness duration (r=−0.53; p=0.02), and the left-to-right BPND ratio correlated inversely with anhedonia ratings (r=−0.65, p=0.0040). The D1 receptor BPND was strongly lateralized in striatal regions (p<0.002 for main effects of hemisphere in accumbens area, putamen, and caudate). In post hoc analyses, a group-by-hemisphere-by-gender interaction was detected in the dorsal putamen, which was accounted for by a loss of the normal asymmetry in depressed women (F=7.33, p=0.01). These data extended a previous finding of decreased striatal D1 receptor binding in an MDD sample manifesting anger attacks to a sample selected more generally according to MDD criteria. Our data also more specifically localized this abnormality in MDD to the left middle caudate, which is the target of afferent neural projections from the orbitofrontal and anterior cingulate cortices where neuropathological changes have been reported in MDD. Finally, D1 receptor binding was asymmetrical across hemispheres in healthy humans, compatible with evidence that dopaminergic function in the striatum is lateralized during reward processing, voluntary movement, and self-stimulation behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 3×
“Since the grey matter volume and/or neuronal counts in these cortical areas is reduced in MDD(Drevets et al. 2008), the regional specificity of the reduction in D1-receptor binding to the MC raises the possibility that this abnormality reflects a reduction in afferent neuronal terminals from the cortex, and thus in th…”
InfluentialSelf-citationThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593 · cited 2×
“…of D1-receptor stimulation is required to facilitate working memory, as intracortical administration of either agonists or antagonists for D1-receptors impairs working memory performance in rodents and primates(Arnsten et al. 1994; Williams and Goldman-Rakic 1995; Granon et al. 2000; Robbins 2000).”
Detecting activations in PET and fMRI: levels of inference and power
Friston, K. J., Holmes, A., Poline, J.-B., Price, C. J., & Frith, C. D. (1996) · NeuroImage · doi:10.1006/nimg.1996.0074 · Cited by 1,148 · cited 1×
“The ability to assess relative differences in radiotracer concentration across conditions in ROI separated by less than the FWHM resolution is central to PET’s utility in localizing voxels of maximal difference in brain mapping studies(Fox et al. 1986; Friston et al. 1996).”
Architectonic subdivision of the human orbital and medial prefrontal cortex
Öngür, D., Ferry, A. T., & Price, J. L. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10609 · Cited by 944 · cited 3×
“, sulcal BA47)(Ongur et al. 2003) and anterior cingulate cortex(ACC; including subgenual and pregenual areas).”
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 5×
“…upper row of images show axial (left) and coronal (right) sections through the anatomical MRI, on which the regions-of-interest (ROI) were defined (Drevets et al. 2001), and the lower row of images show parametric images of the non-displaceable component of the D1-recetor binding potential (BPND)…”
MethodInfluentialSelf-citationHaber, S. N., Kim, K.-S., Mailly, P., & Calzavara, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0271-06.2006 · Cited by 686
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674 · cited 2×
“These observations lead to the hypothesis that reduced mesocorticolimbic DA function underlies the anhedonia, amotivation, and psychomotor slowing associated with major depression (Swerdlow and Koob, 1987; Fibiger, 1991; Nestler and Carlezon, 2006).”
Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys
Arnsten, A. F. T., Cai, J. X., Murphy, B. L., & Goldman-Rakic, P. S. (1994) · Psychopharmacology · doi:10.1007/bf02245056 · Cited by 566 · cited 2×
“These data appeared consistent with evidence that an optimal range of D1-receptor stimulation is required to facilitate working memory, as intracortical administration of either agonists or antagonists for D1-receptors impairs working memory performance in rodents and primates(Arnsten et al. 1994; Williams and Goldman…”
Granon, S., Passetti, F., Thomas, K. L., Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01208.2000 · Cited by 546
Mapping human visual cortex with positron emission tomography
Fox, P. T., Mintun, M. A., Raichle, M. E., Miezin, F. M., Allman, J. M., & Van Essen, D. C. (1986) · Nature · doi:10.1038/323806a0 · Cited by 422 · cited 1×
“The ability to assess relative differences in radiotracer concentration across conditions in ROI separated by less than the FWHM resolution is central to PET’s utility in localizing voxels of maximal difference in brain mapping studies(Fox et al. 1986; Friston et al. 1996).”
Lambert, G., Johansson, M., Ågren, H., & Friberg, P. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.787 · Cited by 303
Lower dopamine transporter binding potential in striatum during depression
Meyer, J. H., Krüger, S., Wilson, A. A., Christensen, B. K., Goulding, V. S., Schaffer, A., Minifie, C., Houle, S., Hussey, D., & Kennedy, S. H. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00052 · Cited by 269
Huang, Y.-Y., Simpson, E., Kellendonk, C., & Kandel, E. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308280101 · Cited by 231 · cited 2×
“Moreover, D1receptor knockout mice showed deficits in fear extinction and reversal learning (putative correlates of resilience to stress or adaptation to behavioral reinforcement, respectively), and abnormal long-term potentiation of synapses on PFC neurons(El-Ghundi et al. 1999; ElGhundi et al. 2001; Huang et al. 200…”
Cannon, D. M., Ichise, M., Rollis, D., Klaver, J. M., Gandhi, S. K., Charney, D. S., Manji, H. K., & Drevets, W. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.016 · Cited by 219
Self-citationHasler, G., Fromm, S., Carlson, P. J., Luckenbaugh, D. A., Waldeck, T., Geraci, M., Roiser, J. P., Neumeister, A., Meyers, N., Charney, D. S., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.521 · Cited by 209 · cited 1×
“Reductions in dopaminergic function associated with alpha-methyl-para-tyrosine administration can induce depressive symptoms in susceptible individuals(Bremner et al. 2003; Hasler et al. 2008).”
Self-citationMartinot, M.-L. P., Bragulat, V., Artiges, E., Dollé, F., Hinnen, F., Jouvent, R., & Martinot, J.-L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.314 · Cited by 194 · cited 2×
“Notably, psychomotor slowing previously was associated with reduced dopaminergic function in the left caudate in MDD, as (Martinot et al. 2001) reported that [18F]DOPA was reduced specifically in the left caudate in MDD patients with psychomotor retardation compared to both healthy controls and MDD patients without ps…”
Koo, M.-S., Levitt, J. J., Salisbury, D. F., Nakamura, M., Shenton, M. E., & McCarley, R. W. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.746 · Cited by 175
D1 dopamine receptor binding in mood disorders measured by positron emission tomography
Suhara, T., Nakayama, K., Inoue, O., Fukuda, H., Shimizu, M., Mori, A., & Tateno, Y. (1992) · Psychopharmacology · doi:10.1007/bf02253582 · Cited by 163 · cited 3×
“…employing neuroimaging or autoradiographic techniques to assess D1-receptor binding in depressed or healthy humans(De Keyser et al. 1988; Suhara et al. 1991; Suhara et al. 1992; Bowden et al. 1997) or experimental animals(Cortes et al. 1989; Camps et al. 1990) did not examine laterality effects.”
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133 · cited 2×
“Nevertheless, studies whose samples were not predominantly composed of psychomotor slowed cases found no difference in D2/3-receptor levels during depression(Klimke et al. 1999; Parsey et al. 2001; Montgomery et al. 2007; Hirvonen et al. 2008).”
PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122 · cited 4×
“Because of the proximity of the MC to other striatal ROI, measured signals from the MC were weakly influenced by those from the AVS and DC which were partly continuous with the MC(Drevets et al.1999, 2001).”
MethodInfluentialSelf-citationBrunswick, D. J., Amsterdam, J. D., Mozley, P. D., & Newberg, A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1836 · Cited by 104
Research works printed but not linked: 74
- Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M et al (2000). Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab 20: 225–243. · DOI · Paper page
- Agren H, Reibring L (1994). PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27: 2–6. · DOI · Paper page
- Andersen PH, Gronvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C et al (1992). NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol 219: 45–52. · DOI
- APA (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). APA Press: Washington, DC.
- Argyelan M, Szabo Z, Kanyo B, Tanacs A, Kovacs Z, Janka Z et al (2005). Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 89: 115–123. · DOI
- Asberg M, Bertilsson L, Martensson B (1984). CSF monoamine metabolites, depression, and suicide. Adv Biochem Psychopharmacol 39: 87–97.
- Bowden C, Theodorou A, Cheetham SC, Lowther S, Katona CL, Crompton MR et al (1997). Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 752: 227–233. · DOI
- Bremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren DA et al (2003). Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA 289: 3125–3134. · DOI · Paper page
- Camps M, Kelly PH, Palacios JM (1990). Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect 80: 105–127. · DOI · Paper page
- Chou YH, Karlsson P, Halldin C, Olsson H, Farde L (1999). A PET study of D (1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology (Berl) 146: 220–227. · DOI
- Cortes R, Gueye B, Pazos A, Probst A, Palacios JM (1989). Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28: 263–273. · DOI · Paper page
- De Keyser J, Dierckx R, Vanderheyden P, Ebinger G, Vauquelin G (1988). D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res 443: 77–84. · DOI
- de la Fuente-Fernandez R, Kishore A, Calne DB, Ruth TJ, Stoessl AJ (2000). Nigrostriatal dopamine system and motor lateralization. Behav Brain Res 112: 63–68. · DOI
- de la Mora MP, Cardenas-Cachon L, Vazquez-Garcia M, Crespo-Ramirez M, Jacobsen K, Hoistad M et al (2005). Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat. Neurosci Lett 377: 101–105. · DOI · Paper page
- Den Boer JA, van Megen HJ, Fleischhacker WW, Louwerens JW, Slaap BR, Westenberg HG et al (1995). Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia. Psychopharmacology (Berl) 121: 317–322. · DOI
- Dougherty DD, Bonab AA, Ottowitz WE, Livni E, Alpert NM, Rauch SL et al (2006). Decreased striatal D1 binding as measured using PET and [11C]SCH 23 390 in patients with major depression with anger attacks. Depress Anxiety 23: 175–177. · DOI · Paper page
- Drevets W (2008). Neural circuits underlying anhedonia in major depressive disorder. Biol Psychiatry 63 (7 supplement 1): 110S.
- Ebert D, Feistel H, Loew T, Pirner A (1996). Dopamine and depression—striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacology (Berl) 126: 91–94. · DOI
- Ekelund J, Narendran R, Guillain O, Castrillon J, Hwang D, Slifstein M et al (2006). Pharmacological selectivity of the in vivo binding of [11C]NNC 112 and [11C]SCH 23390 in the cortex. A PET study in baboons. Neuroimage 31 (Suppl 2): T111. · doi:10.1016/j.neuroimage.2006.04.097
- Ekelund J, Slifstein M, Narendran R, Guillin O, Belani H, Guo NN et al (2007). In vivo DA D (1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 9: 117–125. · DOI
- El-Ghundi M, Fletcher PJ, Drago J, Sibley DR, O'Dowd BF, George SR (1999). Spatial learning deficit in dopamine D (1) receptor knockout mice. Eur J Pharmacol 383: 95–106. · DOI · Paper page
- El-Ghundi M, O'Dowd BF, George SR (2001). Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res 892: 86–93. · DOI
- Ferry AT, Ongur D, An X, Price JL (2000). Prefrontal cortical projections to the striatum in macaque monkeys: evidence for an organization related to prefrontal networks. J Comp Neurol 425: 447–470. · doi:10.1002/1096-9861(20000925)425:3<447::aid-cne9>3.0.co;2-v
- Fibiger HC (1991). The dopamine hypothesis of schizophrenia and mood disorders. In: Willner P, Scheel-Kruger J (eds). The Mesolimbic Dopamine System: From Motivation to Action. Wiley: New York. pp 615–638.
- Gerfen CR, Miyachi S, Paletzki R, Brown P (2002). D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J Neurosci 22: 5042–5054. · DOI · Paper page
- Glick SD, Badalamenti JI (1986). Sex difference in reward asymmetry and effects of cocaine. Neuropharmacology 25: 633–637. · DOI
- Glick SD, Ross DA, Hough LB (1982). Lateral asymmetry of neurotransmitters in human brain. Brain Res 234: 53–63. · DOI · Paper page
- Glick SD, Weaver LM, Meibach RC (1980). Lateralization of reward in rats: differences in reinforcing thresholds. Science 207: 1093–1095. · DOI
- Glick SD, Weaver LM, Meibach RC (1981). Amphetamine enhancement of reward asymmetry. Psychopharmacology (Berl) 73: 323–327. · doi:10.1007/bf00426459
- Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J et al (1998). Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med 39: 2061–2068.
- Hamilton M (1959). The assessment of anxiety states by rating. Brit J Med Psychol 32: 50–55. · DOI · Paper page
- Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Nagren K et al (2008). Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl) 197: 581–590. · DOI
- Holmes A, Lachowicz JE, Sibley DR (2004). Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 47: 1117–1134. · DOI
- Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H et al (2003). Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23: 1096–1112. · DOI · Paper page
- Iyo M, Yamasaki T (1993). The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog Neuropsychopharmacol Biol Psychiatry 17: 415–421. · DOI
- Jenkinson M, Smith S (2001). A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143–156. · DOI · Paper page
- Karle J, Clemmesen L, Hansen L, Andersen M, Andersen J, Fensbo C et al (1995). NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia. Psychopharmacology (Berl) 121: 328–329. · DOI
- Kato T (2007). Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61: 3–19. · DOI · Paper page
- Klimek V, Schenck JE, Han H, Stockmeier CA, Ordway GA (2002). Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry 52: 740–748. · DOI · Paper page
- Klimke A, Larisch R, Janz A, Vosberg H, Muller-Gartner HW, Gaebel W (1999). Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90: 91–101. · DOI
- Koks S, Nikopensius T, Koido K, Maron E, Altmae S, Heinaste E et al (2006). Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol 9: 167–174. · DOI · Paper page
- Lalumiere RT, Nguyen LT, McGaugh JL (2004). Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems. Eur J Neurosci 20: 2804–2810. · DOI · Paper page
- Laruelle M, Huang Y (2001). Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights. Q J Nucl Med 45: 124–138.
- Links JM, Zubieta JK, Meltzer CC, Stumpf MJ, Frost JJ (1996). Influence of spatially heterogeneous background activity on hot object quantitation in brain emission computed tomography. J Comput Assist Tomogr 20: 680–687. · DOI · Paper page
- Liu ZH, Shin R, Ikemoto S (2008). Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacology. February 6, 2008 · DOI
- ([epub ahead of print] doi: 10.1038/npp.2008.4) · DOI
- Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C (1998). A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inform (Lond) 23: 207–214. · DOI · Paper page
- Montgomery AJ, Stokes P, Kitamura Y, Grasby PM (2007). Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride. J Affect Disord 101: 113–122. · DOI
- Montgomery S, Asberg M (1979). A new depression scale designed to be sensitive to change. Brit J Psychiat 134: 382–389. · DOI · Paper page
- Nutt DJ, Baldwin DS, Clayton AH, Elgie R, Lecrubier Y, Montejo AL et al (2006). Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 67 (Suppl 6): 46–49.
- Papp M, Klimek V, Willner P (1994). Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) 115: 441–446. · DOI · Paper page
- Pimoule C, Schoemaker H, Reynolds GP, Langer SZ (1985). [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. Eur J Pharmacol 114: 235–237. · DOI
- Robbins TW (2000). Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133: 130–138. · DOI · Paper page
- Romach MK, Glue P, Kampman K, Kaplan HL, Somer GR, Poole S et al (1999). Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166). Arch Gen Psychiatry 56: 1101–1106. · DOI · Paper page
- Savitz J, van der Merwe L, Solms M, Ramesar R (2007). Lateralization of hand skill in bipolar affective disorder. Genes Brain Behav 6: 698–705. · DOI
- Schultz W (1997). Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 7: 191–197. · DOI · Paper page
- Severino G, Congiu D, Serreli C, De Lisa R, Chillotti C, Del Zompo M et al (2005). A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 134B: 37–38. · DOI
- Shinotoh H, Inoue O, Hirayama K, Aotsuka A, Asahina M, Suhara T et al (1993). Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 56: 467–472. · DOI
- Silva MA, Topic B, Lamounier-Zepter V, Huston JP, Tomaz C, Barros M (2007). Evidence for hemispheric specialization in the marmoset (Callithrix penicillata) based on lateralization of behavioral/neurochemical correlations. Brain Res Bull 74: 416–428. · DOI
- Slifstein M, Kegeles LS, Gonzales R, Frankle WG, Xu X, Laruelle M et al (2007). [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT (2A) receptors: a PET study in healthy human subjects. J Cereb Blood Flow Metab 27: 1733–1741. · DOI
- Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T et al (1991). Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology (Berl) 103: 41–45. · DOI · Paper page
- Suzuki M, Hatano K, Sakiyama Y, Kawasumi Y, Kato T, Ito K (2001). Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography. Synapse 41: 285–293. · DOI
- Tavares JV, Drevets WC, Sahakian BJ (2003). Cognition in mania and depression. Psychol Med 33: 959–967. · DOI · Paper page
- Todd RD, Carl J, Harmon S, O'Malley KL, Perlmutter JS (1996). Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons. J Neurosci 16: 7776–7782. · DOI
- Tomer R, Goldstein RZ, Wang GJ, Wong C, Volkow ND (2008). Incentive motivation is associated with striatal dopamine asymmetry. Biol Psychol 77: 98–101. · DOI · Paper page
- van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM et al (2002). Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 10: 36–43. · DOI · Paper page
- Waddington JL, Clifford JJ, McNamara FN, Tomiyama K, Koshikawa N, Croke DT (2001). The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion (‘knockout’). Prog Neuropsychopharmacol Biol Psychiatry 25: 925–964. · DOI
- Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M et al (1998). Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 30: 56–61. · DOI
- Willner P (1995). Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, pp 921–932.
- Willner P (2000). Dopaminergic mechanisms in depression and mania. In: Bloom FaK, D (ed). Neuropsychopharmacology. The Fourth Generation of Progress, Raven Press, New York.
- Woods RP, Cherry SR, Mazziotta JC (1992). Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16: 620–633. · DOI · Paper page
- Yamamoto BK, Lane RF, Freed CR (1982). Normal rats trained to circle show asymmetric caudate dopamine release. Life Sci 30: 2155–2162. · DOI
- Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT et al (2008). Greater availability of dopamine transporters in patients with major depression—a dual-isotope SPECT study. Psychiatry Res 162: 230–235. · DOI
- Zarate Jr CA, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD et al (2004). Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 56: 54–60. · DOI · Paper page
Cited by
Cognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Self-citationReconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
“As for D1-like receptors, a recent study of D1 receptors using PET-[11C]NNC-112 found reduced D1-like receptor binding in the striatum bilaterally in a sample of individuals with MDD (Cannon et al., 2009).”
BackgroundInflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Neurobiology of chronic mild stress: parallels to major depression
Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., & Weinberg, J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.001 · Cited by 420
“Increases in D2 eceptor binding in the putamen have been documented (Meyer t al., 2006), as well as reductions in striatal D1 receptor binding Dougherty et al., 2006; Cannon et al., 2009).”
Background
Metadata
- Authors
- Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis-Voak, D., Erickson, K., & Drevets, W. C.
- Venue
- Neuropsychopharmacology
- Published
- 2008-10-22
- Volume
- 34
- Issue
- 5
- Pages
- 1277-1287
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2023193193
- Cited by
- 118
- References
- 23
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.